Literature DB >> 7797084

Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period.

K Tuppurainen1.   

Abstract

BACKGROUND: Basal cell carcinoma (BCC) is the most common of all malignant tumours and often appears on the periocular skin. In the present study, patients with 166 eyelid and periocular BCCs were treated with cryotherapy at the Eye Clinic of the Kuopio University Hospital. Seven patients with a total of eight BCCs died during the first year after cryotherapy, of causes unrelated to BCC. These cases were excluded from the analysis of outcome.
METHOD: The tumours were photographed before excisional biopsy and histopathological examination. The BCCs were frozen twice with liquid nitrogen in a closed cryoprobe; a tissue thermometer was used.
RESULTS: During the mean follow-up of 5 years for 158 BCCs, recurrences were observed in 12 cases (7.6%). The most important prognostic factors for recurrence were large tumour size (maximum diameter exceeding 10 mm), tumour extension into the lid margin, and cicatrising (morpheaform) BCC. The complications of cryotherapy were slight, but in some cases lid ectropion needed surgical correction. The functional and cosmetic results were very satisfactory in most cases.
CONCLUSION: Ninety-two percent of BBCs treated with cryotherapy did not recur during mean follow-up of 5.0 years (range 1.6-8.4 years).

Entities:  

Mesh:

Year:  1995        PMID: 7797084     DOI: 10.1007/bf00183593

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Cryosurgical management of basal cell carcinoma of the eyelid: a 10-year experience.

Authors:  L Biro; E Price
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

2.  [Cryotherapy in basalioma].

Authors:  W Matthäus; G Sebastian; A Scholz
Journal:  Arch Geschwulstforsch       Date:  1977

3.  A biochemical and immunohistochemical study of collagen in sun-exposed and protected skin.

Authors:  A Oikarinen; M Kallioinen
Journal:  Photodermatol       Date:  1989-02

4.  [15 years' experiences with cryotherapy of eyelid, facial and conjunctival tumors in 2,745 cases].

Authors:  W Matthäus
Journal:  Fortschr Ophthalmol       Date:  1987

5.  Cryosurgery for carcinoma of the eyelids: a 12-year experience.

Authors:  E G Kuflik
Journal:  J Dermatol Surg Oncol       Date:  1985-03

6.  Cryosurgery of eyelid basal cell carcinomas.

Authors:  G Gunnarson; O Larkö; K Hersle
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-06

7.  Effects of systemic corticosteroids on post-cryosurgical edema and other manifestations of the inflammatory response.

Authors:  E G Kuflik; W Webb
Journal:  J Dermatol Surg Oncol       Date:  1985-05

Review 8.  Basal cell carcinoma of the eyelid and periocular skin.

Authors:  C E Margo; K Waltz
Journal:  Surv Ophthalmol       Date:  1993 Sep-Oct       Impact factor: 6.048

9.  The biologic behavior of basal cell carcinoma: Part I.

Authors:  D J Hauben; H Zirkin; D Mahler; M Sacks
Journal:  Plast Reconstr Surg       Date:  1982-01       Impact factor: 4.730

10.  [Indications and results of cryotherapy of eyelid tumors].

Authors:  F H Prskavec
Journal:  Wien Klin Wochenschr       Date:  1986-05-02       Impact factor: 1.704

View more
  4 in total

Review 1.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

2.  A reappraisal of cryosurgery for eyelid basal cell carcinomas.

Authors:  W Buschmann
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Evaluation of carbon dioxide laser therapy for benign tumors of the eyelid margin.

Authors:  Aniko Rentka; Jan Grygar; Zoltan Nemes; Adam Kemeny-Beke
Journal:  Lasers Med Sci       Date:  2017-09-02       Impact factor: 3.161

4.  Histological and clinical features of primary and recurrent periocular Basal cell carcinoma.

Authors:  Guy J Ben Simon; Semion Lukovetsky; Fabio Lavinsky; Nahum Rosen; Mordechai Rosner
Journal:  ISRN Ophthalmol       Date:  2012-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.